Sat, Dec 20, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

UCITS Alternative Index Global up 0.5% in September, 2.00% year to date

Thursday, October 03, 2013
Opalesque Industry Update - The UCITS Alternative Index Global advanced by 0.65% in September and is now up 2.00% for the year. The positive performance is due to the good results of Long/Short Equity funds - up 1.61% - as well as Emerging Markets and Event-Driven funds - up respectively 1.19% and 0.93%. September proved to be a more challenging month for UCITS Commodities and UCITS FX funds, down -1.88% and -1.08%. With -0.41% in September UCITS CTA managers record their fifth consecutive month with negative performance and are now down -2.33% for the year.

UCITS Long/Short Equity funds are by far the best performing strategy this year with 6.96%. They are followed by Event Driven funds up 2.79% and Multi-Strategy up 2.14%. On the negative side, three strategy indices are down more the 3% for the year. The UAI Volatility is down -3.36%, the UAI FX -3.31% and the UAI Commodities -3.19%. September is a good month for UCITS funds of funds. They progress by 0.80% and are now up 2.50% for the year. The relative good performance of funds of funds is explained by their large tilt towards Long/Short Equity funds.

UAI Blue Chip: The UAI Blue Chip is up 0.47% for the month and 2.03% for 2013. Emerging Markets and Event Driven funds return the best performance with an average progression of 3.27% and 2.48%. With 26bp Emerging Market funds deliver the largest positive performance contribution, followed by Fixed Income funds with 9bp and Long/Short Equity funds with 8bp.

UAIX Indices: UAIX indices display mixed performance in September with only 7 out of 12 strategy indices ending the month with positive returns. The best performing index is the UAIX Emerging Markets up 1.87%. It is followed by the UAIX Event-Driven and the UAIX Long/Short Equity up 1.29% and 1.12%. The UAIX CTA is the worst performing strategy index this month with -1.36%. Since the beginning of the year the best performing index is the UAIX Long/Short Equity with a progression of 8.86% as of the end of September.

AUM and number of funds:

The total assets managed by single UCITS hedge funds increased to EUR 174 billion at the end of September. The UCITS Alternative Index is currently composed of more than 840 UCITS absolute return funds and funds of funds.

Press release

BC

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und